Literature DB >> 12126826

Incidence of Creutzfeldt-Jakob disease in Switzerland.

Markus Glatzel1, Colette Rogivue, Azra Ghani, Johannes R Streffer, Lorenz Amsler, Adriano Aguzzi.   

Abstract

The incidence of Creutzfeldt-Jakob disease (CJD) in Switzerland increased two-fold in 2001, and figures from the first quarter of 2002 indicate that it continues to rise. Neither age at onset nor duration of disease were different from previous years. Genetic analysis of the 27 reported cases revealed only one disease-associated mutation in the prion gene. None of the recognised risk factors for acquired CJD were reported on the official notification forms. Glycotype profiling, histopathology, and immunohistochemistry indicate that none of the cases fulfilled the definition of variant CJD, which is thought to be caused by bovine prions. Several scenarios could account for the increase in CJD, including improved reporting, iatrogenic transmission, and transmission of a prion zoonosis.

Entities:  

Mesh:

Year:  2002        PMID: 12126826     DOI: 10.1016/S0140-6736(02)09384-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance.

Authors:  Chien-Jung Lu; Yu Sun; Shun-Sheng Chen
Journal:  Eur J Epidemiol       Date:  2010-03-24       Impact factor: 8.082

3.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  No reactivation of JCV and CMV infections in the temporal cortex and cerebellum of sporadic Creutzfeldt-Jakob disease patients.

Authors:  Judith Löffler; Susanne Krasemann; Inga Zerr; Jakob Matschke; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

5.  Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

Authors:  Susanne Krasemann; Melanie Neumann; Markus Geissen; Walter Bodemer; Franz-Josef Kaup; Walter Schulz-Schaeffer; Nathalie Morel; Adriano Aguzzi; Markus Glatzel
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

6.  Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.

Authors:  Mara Popović; Damjan Glavac; Sava Smerkolj; Viktor Svigelj; Gregor Kalan; Vesna Galvani; Maja Cernilec; Maja Bresjanac
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

7.  [Proportion of tau protein to phosphorylated tau protein CSF levels in differential diagnosis of dementia].

Authors:  J Hort; M Valis; G Waberzinek; R Taláb; L Glossová; M Bojar; M Vyhnálek; D Skoda; J Masopust; P Stourac
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

8.  Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies.

Authors:  Ignacio Mahillo-Fernandez; Jesús de Pedro-Cuesta; Maria José Bleda; Mabel Cruz; Kåre Mølbak; Henning Laursen; Gerhard Falkenhorst; Pablo Martínez-Martín; Ake Siden
Journal:  Neuroepidemiology       Date:  2008-10-09       Impact factor: 3.282

9.  Movement disorders reveal Creutzfeldt-Jakob disease.

Authors:  Michael Weller; Adriano Aguzzi
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 10.  Variant Creutzfeldt-Jakob disease.

Authors:  Esther A Croes; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.